Resveratrol alleviates endotoxemia-associated adrenal insufficiency by suppressing oxidative/nitrative stress

Endocrine Journal

Volumn 63, Issue 6, 2016, Pages 569-580

  Duan, Guo Li ^a,b   Wang, Chang Nan ^a   Liu, Yu Jian ^c   Yu, Qing ^a   Tang, Xiao Lu ^a   Ni, Xin ^a   Zhu, Xiao Yan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY OF SPORT   (China)

Author keywords

Adrenocortical insufficiency; Endotoxemia; Nitrative stress; Oxidative stress; Resveratrol

Indexed keywords

CATALASE; CORTICOSTERONE; CORTICOTROPIN; DEXAMETHASONE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MALONALDEHYDE; MELANOCORTIN 2 RECEPTOR; NITRIC OXIDE; PEROXYNITRITE; RESVERATROL; SIRTUIN 1; SUPEROXIDE DISMUTASE; ANTIOXIDANT; LIPOPOLYSACCHARIDE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STILBENE DERIVATIVE;

ADRENAL GLAND; ADRENAL INSUFFICIENCY; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLEEDING; CELL INFILTRATION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN TEST; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; ENDOTOXEMIA; ENZYME ACTIVITY; HISTOPATHOLOGY; LEUKOCYTE; MALE; MOUSE; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; TOTAL ANTIOXIDANT CAPACITY; VERY ELDERLY; ANIMAL; CELL PROTECTION; CHEMICALLY INDUCED; COMPLICATION; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID PEROXIDATION; METABOLISM;

ADRENAL GLANDS; ADRENAL INSUFFICIENCY; ANIMALS; ANTIOXIDANTS; CYTOPROTECTION; ENDOTOXEMIA; LIPID PEROXIDATION; LIPOPOLYSACCHARIDES; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84976485397     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ15-0610     Document Type: Article

References (43)

1. Neary N, Nieman L (2010) Adrenal insufficiency: etiology, diagnosis and treatment. Curr Opin Endocrinol Diabetes Obes 17: 217-223.
2. Tsai MH, Peng YS, Chen YC, Liu NJ, Ho YP, et al. (2006) Adrenal insufficiency in patients with cirrhosis, severe sepsis and septic shock. Hepatology 43: 673-681.
3. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, et al. (2007) Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 35: 1012-1018.
4. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, et al. (2008) Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 36: 1937-1949.
5. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, et al. (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41: 580-637.
6. Malikova J, Fluck CE (2014) Novel insight into etiology, diagnosis and management of primary adrenal insufficiency. Horm Res Paediatr 82: 145-157.
7. Prasad R, Kowalczyk JC, Meimaridou E, Storr HL, Metherell LA (2014) Oxidative stress and adrenocortical insufficiency. J Endocrinol 221: R63-73.
8. Roberts RA, Laskin DL, Smith CV, Robertson FM, Allen EM, et al. (2009) Nitrative and oxidative stress in toxicology and disease. Toxicol Sci 112: 4-16.
9. King RE, Kent KD, Bomser JA (2005) Resveratrol reduces oxidation and proliferation of human retinal pigment epithelial cells via extracellular signalregulated kinase inhibition. Chem Biol Interact 151: 143-149.
10. Knutson MD, Leeuwenburgh C (2008) Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Nutr Rev 66: 591-596.
11. Kuno A, Tanno M, Horio Y (2015) The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy. Ann N Y Acad Sci 1348: 46-54.
12. Zhang HX, Duan GL, Wang CN, Zhang YQ, Zhu XY, et al. (2014) Protective effect of resveratrol against endotoxemia-induced lung injury involves the reduction of oxidative/nitrative stress. Pulm Pharmacol Ther 27: 150-155.
13. Jeon BT, Jeong EA, Shin HJ, Lee Y, Lee DH, et al. (2012) Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 61: 1444-1454.
14. Wang CN, Liu YJ, Duan GL, Zhao W, Li XH, et al. (2014) CBS and CSE are critical for maintenance of mitochondrial function and glucocorticoid production in adrenal cortex. Antioxid Redox Signal 21: 2192-2207.
15. Wang CN, Duan GL, Liu YJ, Yu Q, Tang XL, et al. (2015) Overproduction of nitric oxide by endothelial cells and macrophages contributes to mitochondrial oxidative stress in adrenocortical cells and adrenal insufficiency during endotoxemia. Free Radic Biol Med 83: 31-40.
16. Yang T, Mao YF, Liu SQ, Hou J, Cai ZY, et al. (2010) Protective effects of the free radical scavenger edaravone on acute pancreatitis-associated lung injury. Eur J Pharmacol 630: 152-157.
17. Jones DP (2006) Redefining oxidative stress. Antioxid Redox Signal 8: 1865-1879.
18. Liu S, Zhu X, Liu Y, Wang C, Wang S, et al. (2011) Endotoxin tolerance of adrenal gland: attenuation of corticosterone production in response to lipopolysaccharide and adrenocorticotropic hormone. Crit Care Med 39: 518-526.
19. Yun JM, Chien A, Jialal I, Devaraj S (2012) Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights. J Nutr Biochem 23: 699-705.
20. Ziolkowska A, Belloni AS, Nussdorfer GG, Nowak M, Malendowicz LK (2006) Endocrine disruptors and rat adrenocortical function: studies on freshly dispersed and cultured cells. Int J Mol Med 18: 1165-1168.
21. Supornsilchai V, Svechnikov K, Seidlova-Wuttke D, Wuttke W, Soder O (2005) Phytoestrogen resveratrol suppresses steroidogenesis by rat adrenocortical cells by inhibiting cytochrome P450 c21-hydroxylase. Horm Res 64: 280-286.
22. Chandra AK, Ghosh R, Chatterjee A, Sarkar M (2007) Amelioration of vanadium-induced testicular toxicity and adrenocortical hyperactivity by vitamin E acetate in rats. Mol Cell Biochem 306: 189-200.
23. Liu S, Zhang XP, Han NN, Lv S, Xiong JY (2015) Pretreatment with low dose etomidate prevents etomidate-induced rat adrenal insufficiency by regulating oxidative stress-related MAPKs and apoptosis. Environ Toxicol Pharmacol 39: 1212-1220.
24. Floreani M, Napoli E, Quintieri L, Palatini P (2003) Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. Life Sci 72: 2741-2750.
25. Moridi H, Karimi J, Sheikh N, Goodarzi MT, Saidijam M, et al. (2015) Resveratrol-Dependent Downregulation of Receptor for Advanced Glycation Endproducts and Oxidative Stress in Kidney of Rats With Diabetes. Int J Endocrinol Metab 13: e23542.
26. Palsamy P, Subramanian S (2011) Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling. Biochim Biophys Acta 1812: 719-731.
27. Gutierrez-Perez A, Cortes-Rojo C, Noriega-Cisneros R, Calderon-Cortes E, Manzo-Avalos S, et al. (2011) Protective effects of resveratrol on calcium-induced oxidative stress in rat heart mitochondria. J Bioenerg Biomembr 43: 101-107.
28. Abidi P, Zhang H, Zaidi SM, Shen WJ, Leers-Sucheta S, et al. (2008) Oxidative stress-induced inhibition of adrenal steroidogenesis requires participation of p38 mitogen-activated protein kinase signaling pathway. J Endocrinol 198: 193-207.
29. Astort F, Repetto EM, Martinez Calejman C, Cipelli JM, Sanchez R, et al. (2009) High glucose-induced changes in steroid production in adrenal cells. Diabetes Metab Res Rev 25: 477-486.
30. Baumgarten G, Knuefermann P, Schuhmacher G, Vervolgyi V, von Rappard J, et al. (2006) Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia. Shock 25: 43-49.
31. Cohen RI, Hassell AM, Marzouk K, Marini C, Liu SF, et al. (2001) Renal effects of nitric oxide in endotoxemia. Am J Respir Crit Care Med 164: 1890-1895.
32. Ishikawa K, Calzavacca P, Bellomo R, Bailey M, May CN (2012) Effect of selective inhibition of renal inducible nitric oxide synthase on renal blood flow and function in experimental hyperdynamic sepsis. Crit Care Med 40: 2368-2375.
33. La Mura V, Pasarin M, Rodriguez-Vilarrupla A, Garcia-Pagan JC, Bosch J, et al. (2014) Liver sinusoidal endothelial dysfunction after LPS administration: a role for inducible-nitric oxide synthase. J Hepatol 61: 1321-1327.
34. Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, et al. (2006) Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogen-esis and tyrosine kinase receptor Flk-1. Cell Biochem Biophys 44: 43-49.
35. Kim WT, Suh ES (2010) Retinal protective effects of resveratrol via modulation of nitric oxide synthase on oxygen-induced retinopathy. Korean J Ophthalmol 24: 108-118.
36. Ekshyyan VP, Hebert VY, Khandelwal A, Dugas TR (2007) Resveratrol inhibits rat aortic vascular smooth muscle cell proliferation via estrogen receptor dependent nitric oxide production. J Cardiovasc Pharmacol 50: 83-93.
37. Chung EY, Kim BH, Hong JT, Lee CK, Ahn B, et al. (2011) Resveratrol down-regulates interferon-gammainducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. J Nutr Biochem 22: 902-909.
38. Mannam P, Zhang X, Shan P, Zhang Y, Shinn AS, et al. (2013) Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury. J Immunol 190: 1264-1275.
39. La Mura V, Pasarin M, Meireles CZ, Miquel R, Rodriguez-Vilarrupla A, et al. (2013) Effects of simvastatin administration on rodents with lipopolysaccharideinduced liver microvascular dysfunction. Hepatology 57: 1172-1181.
40. Hughes CG, Morandi A, Girard TD, Riedel B, Thompson JL, et al. (2013) Association between endothelial dysfunction and acute brain dysfunction during critical illness. Anesthesiology 118: 631-639.
41. Polito A, Lorin de la Grandmaison G, Mansart A, Louiset E, Lefebvre H, et al. (2010) Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals. Intensive Care Med 36: 1852-1858.
42. Jahangir-Hekmat M, Taylor HC, Levin H, Wilbur M, Llerena LA (2004) Adrenal insufficiency attributable to adrenal hemorrhage: long-term follow-up with reference to glucocorticoid and mineralocorticoid function and replacement. Endocr Pract 10: 55-61.
43. Dong WW, Liu YJ, Lv Z, Mao YF, Wang YW, et al. (2015) Lung endothelial barrier protection by resveratrol involves inhibition of HMGB1 release and HMGB1-induced mitochondrial oxidative damage via an Nrf2-dependent mechanism. Free Radic Biol Med 88: 404-416.